Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-21

Clinical Trial Update: EPIC European Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting [NA]

View source ↗

Summary

This document reports the completion status of the EPIC European Study evaluating the FiberNet Emboli Protection Device in carotid artery stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FiberNet Emboli Protection Device

Snippet

Sponsor: Lumen Biomedical | Conditions: Carotid Artery Stenosis | NA | Status: COMPLETED